10.24335/L28262
RoyaltyStat
Joint research and development, with exclusive patent and know-how license to develop, produce, out-license, commercialize, market, sell and sublicense products containing the 'Axenohl' and 'Axen' silver dihydrogen citrate and ionic silver technology in the medical, dental and veterinary fields for human or animal health, requiring agency approval and a prescription, including drugs, devices, sterilants and diagnostics.
RoyaltyStat
2003